BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3034442)

  • 21. [Investigations on immunity against poliomyelitis (author's transl)].
    Haas R; Petersen EE; Neumann-Haefelin D; Doerr HW; Eggert E; Enders G; Firtzlaff R; Kuwert E; Lennartz H; Schmidt WA
    Dtsch Med Wochenschr; 1975 Jan; 100(1):3-8. PubMed ID: 163177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herd immunity to poliovirus in Dundee.
    Smith WC; Small RG; Dunkerley RA; Green DM
    Health Bull (Edinb); 1982 Nov; 40(6):296-305. PubMed ID: 6298147
    [No Abstract]   [Full Text] [Related]  

  • 23. [IgM-specific neutralizing antibodies against poliovirus in cases of poliomyelitis].
    Salmerón García F
    Bol Oficina Sanit Panam; 1982 Mar; 92(3):203-7. PubMed ID: 6279126
    [No Abstract]   [Full Text] [Related]  

  • 24. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of poliovirus neutralizing antibodies. A seroepidemiologic survey of vaccinated and unvaccinated women of fertile age.
    Moschen ME; Farisano G; Bonello C; Benussi G; Barbone F; Gasparini V; Trivello R
    Boll Ist Sieroter Milan; 1987; 66(2):97-100. PubMed ID: 2822063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
    Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
    Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitoxic immunity of the population against diphtheria in Singapore.
    Goh KT; Yamazaki S
    Trop Geogr Med; 1987 Apr; 39(2):177-81. PubMed ID: 3629713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Poliomyelitis in The Netherlands, 1979-1991: immunity and exposure].
    Rümke HC; Oostvogel PM; van der Veer M; van Steenis G; van Loon AM
    Ned Tijdschr Geneeskd; 1993 Jul; 137(28):1380-6. PubMed ID: 8240513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of varicella-zoster virus infection in Singapore.
    Ooi PL; Goh KT; Doraisingham S; Ling AE
    Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):22-5. PubMed ID: 1523475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune status of children one to four years of age as determined by history and antibody measurement.
    Gold E; Fevrier A; Hatch MH; Herrmann KL; Jones WL; Krugman RD; Parkman PD
    N Engl J Med; 1973 Aug; 289(5):231-5. PubMed ID: 4351596
    [No Abstract]   [Full Text] [Related]  

  • 32. Eradication of poliomyelitis in Cuba: a historical perspective.
    Más Lago P
    Bull World Health Organ; 1999; 77(8):681-7. PubMed ID: 10516790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artificial herd immunity to poliomyelitis in a semirural community in South Africa.
    Winter PA; Krynauw JD; Marais GA
    S Afr Med J; 1981 Dec; 60(23):889-90. PubMed ID: 6272430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics of the dynamics of herd immunity to the poliovirus and of the quality of the vaccination carried out against poliomyelitis].
    Vlasova LV; Vaserin IuI; Stepanova GP; Zakirova SF; Venediktova NIa
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):75-8. PubMed ID: 6303022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The level of herd immunity against poliomyelitis in children during the mass vaccinal prophylaxis of this infection].
    Spynu KI; Buzdugan GI; Vutkarev VP
    Vopr Virusol; 1986; 31(5):602-5. PubMed ID: 3026095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunity to poliomyelitis in The Netherlands.
    Conyn-Van Spaendonck MA; de Melker HE; Abbink F; Elzinga-Gholizadea N; Kimman TG; van Loon T
    Am J Epidemiol; 2001 Feb; 153(3):207-14. PubMed ID: 11157405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune status of children of immigrants to poliomyelitis.
    Bell EJ; McDaid R; Dewar RD; Goel KM; Reid D; Grist NR
    Br Med J; 1978 Jan; 1(6104):16-8. PubMed ID: 202366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of neutralizing antibody responses against poliovirus types 1, 2 and 3 in the Tripoli area of the Socialist People's Libyan Arab Jamahiriya.
    el Nageh M; Khadre MA; Gould EA
    Trans R Soc Trop Med Hyg; 1988; 82(5):758-60. PubMed ID: 2855283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Stage of immunity to Poliovirus type 1 and 3 in adult women and in newborn infants: study of comparative efficiency of 2 methods for determination of neutralizing antibodies].
    Barbi M
    Ann Sclavo; 1972; 14(6):694-704. PubMed ID: 4360238
    [No Abstract]   [Full Text] [Related]  

  • 40. Seroimmunity to poliomyelitis in an American community.
    Oberhofer TR; Brown GC; Monto AS
    Am J Epidemiol; 1975 Apr; 101(4):333-9. PubMed ID: 164770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.